{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:06:45Z","timestamp":1761581205391,"version":"3.44.0"},"reference-count":10,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2014,5,25]]},"abstract":"<jats:p>A 45-year-old woman, known case of seronegative arthritis and on immunosuppressive therapy, presented with a 2-week history of a macular lesion on the left calf that became papular and eventually ulcerated. The rest of the history was otherwise unremarkable and systemic examination did not reveal any abnormalities. The lesion was repeatedly biopsied but failed to reveal <jats:italic>Leishmania donovani<\/jats:italic> bodies. Concurrent <jats:italic>Leishmania<\/jats:italic> IgG was positive but IgM was negative. <jats:italic>Leishmania<\/jats:italic> IgG confirmatory testing by ELISA was negative. A biopsy from the lesion eventually tested positive for <jats:italic>L. donovani<\/jats:italic> through PCR. The patient was treated with sodium stibogluconate together with intravenous ciprofloxacin and amoxicillin to cover the secondary cutaneous bacterial infection. This led to complete resolution of the lesion.<\/jats:p>","DOI":"10.1136\/bcr-2014-204914","type":"journal-article","created":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T06:14:02Z","timestamp":1402380842000},"page":"bcr2014204914","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Atypical cutaneous leishmaniasis in the immunosuppressed"],"prefix":"10.1136","volume":"2014","author":[{"given":"Clayton","family":"Micallef","sequence":"first","affiliation":[{"name":"Department of Medicine Foundation Programme, Mater Dei Hospital, Msida, Malta"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Mallia Azzopardi","sequence":"additional","affiliation":[{"name":"Infectious Disease Unit, Mater Dei Hospital, Msida, Malta"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2014,6,10]]},"reference":[{"key":"2025082722582388000_2014.jun10_1.bcr2014204914.1","unstructured":"Wolff K Johnson RA Saavedra AP . Systemic parasitic infections. Fitzpatrick's color atlas and synopsis of clinical dermatology. 1983 Reprint. New York, USA: McGraw-Hill, 2013:721\u20135."},{"key":"2025082722582388000_2014.jun10_1.bcr2014204914.2","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3201\/eid1506.090101","article-title":"Leishmaniasis, autoimmune rheumatic disease, and anti-tumor necrosis factor therapy, Europe","volume":"15 .","author":"Xynos","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"2025082722582388000_2014.jun10_1.bcr2014204914.3","doi-asserted-by":"publisher","DOI":"10.1590\/S0036-46652005000400003"},{"key":"2025082722582388000_2014.jun10_1.bcr2014204914.4","doi-asserted-by":"crossref","unstructured":"Romero-Mat\u00e9 A Mart\u00ednez-S\u00e1nchez D Tard\u00edo JC . Cutaneous leishmaniasis with histopathologic pattern of non-necrotizing granulomatous dermatitis in patients treated with adalimumab. Dermatol Online J 2012;18:7.","DOI":"10.5070\/D30C96W76K"},{"key":"2025082722582388000_2014.jun10_1.bcr2014204914.5","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2006.047340"},{"key":"2025082722582388000_2014.jun10_1.bcr2014204914.6","first-page":"337","article-title":"Molecular identification of Leishmania species using samples obtained from negative stained smears","volume":"8","author":"Mohaghegh","year":"2013","journal-title":"Iran J Parasitol"},{"key":"2025082722582388000_2014.jun10_1.bcr2014204914.7","doi-asserted-by":"publisher","DOI":"10.1159\/000063150"},{"key":"2025082722582388000_2014.jun10_1.bcr2014204914.8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3855\/jidc.511","article-title":"PCR detection of Leishmania in skin biopsies","volume":"3","author":"Lemrani","year":"2009","journal-title":"J Infect Dev Ctries"},{"key":"2025082722582388000_2014.jun10_1.bcr2014204914.9","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1469-0691.2011.03674.x","article-title":"Tumor necrosis factor alpha antagonist drugs and leishmaniasis in Europe","volume":"18","author":"Zanger","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"2025082722582388000_2014.jun10_1.bcr2014204914.10","doi-asserted-by":"crossref","first-page":"20542","DOI":"10.2807\/1560-7917.ES2013.18.30.20542","article-title":"Leishmaniasis in the era of tumor necrosis factor alpha antagonist therapy\u2014a research agenda for Europe","volume":"18","author":"Zanger","year":"2013","journal-title":"Eur Surveill"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2014-204914","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T05:58:33Z","timestamp":1756360713000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2014-204914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,10]]},"references-count":10,"alternative-id":["10.1136\/bcr-2014-204914"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2014-204914","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2014,6,10]]}}}